Macmiror Complex

Nystatin, the active ingredient in Macmiror Complex, is an antifungal/antimicrobial presented as a vaginal formulation for vaginal use. It treats vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in women. GNH USA supplies Macmiror Complex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macmiror Complex combines two agents that act against fungal, bacterial and protozoal pathogens causing vaginal infections. - Vulvovaginal candidiasis: reduces fungal load and relieves itching, burning and discharge. - Bacterial vaginosis: suppresses anaerobic bacterial overgrowth and restores normal flora. - Trichomoniasis: eliminates Trichomonas vaginalis, decreasing irritation and abnormal discharge.

Adverse reactions may occur with any vaginal anti‑infective preparation.

Common Side Effects: - Local irritation or burning sensation. - Vaginal itching or mild rash. - Increased vaginal discharge of a different colour. - Mild abdominal discomfort.

Serious or Rare Side Effects: - Allergic reaction with swelling of the face, lips or tongue. - Severe vaginal ulceration or necrosis. - Systemic hypersensitivity manifesting as fever or rash. - Rare hepatic dysfunction with elevated liver enzymes.

Use Macmiror Complex only under medical supervision and consider the following precautions. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a clinician. - Known hypersensitivity: avoid if allergic to nystatin, nifuratel or excipients. - Concurrent vaginal products: do not use other medicated creams or douches simultaneously. - Underlying conditions: inform the prescriber of any chronic illnesses, especially liver disease. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Macmiror Complex may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Systemic antifungals (e.g., amphotericin B) that could increase toxicity when combined. - Oral antibiotics that dramatically alter vaginal flora, potentially reducing efficacy.

Moderate Interactions (Monitor Closely): - Topical steroids applied to the vagina, which may mask local irritation. - Hormonal contraceptives, as altered flora could affect absorption. - Anticoagulants, if systemic absorption occurs, may affect clotting parameters.